Eli Lilly (NY: LLY )

931.68 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,057
Open 931.68
Bid (Size) 930.36 (1)
Ask (Size) 938.00 (1)
Prev. Close 931.68
Today's Range 931.68 - 931.68
52wk Range 516.57 - 966.10
Shares Outstanding N/A
Dividend Yield 0.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Biotech Stocks to Buy on the Dip: August 2024
These are three of the best biotech stocks to buy on the dip due to their strong fundamentals and market positioning. 
Via InvestorPlace
Don't Promote Copycat Weight-Loss Drugs Amid Improved Supply, Eli Lilly Asks Doctors, FDA Evaluates
Eli Lilly issues cease-and-desist letters to healthcare providers, demanding they stop promoting compounded weight-loss drugs as supply improves. The move has sparked tension, with providers arguing... 
Via Benzinga
Exposures Product Safety

Performance

YTD
+57.33%
+57.33%
1 Month
-1.98%
-1.98%
3 Month
+18.38%
+18.38%
6 Month
+23.02%
+23.02%
1 Year
+70.44%
+70.44%

More News

Read More
Eli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters
Via Benzinga
Up 10% in 1 Day, Is It Too Late to Buy Eli Lilly Stock?
Via The Motley Fool
Being Vain Has Its Benefits. Why Eli Lilly And The 'Me-Conomy' Are Here To Stay.
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years
Via Benzinga
Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock
Via Benzinga
Prediction: The Next Big Biotech Stock Boom Will Be in Longevity Drugs
Via The Motley Fool
3 Stocks on the Rise After Stellar Q2 Earnings Results
Via InvestorPlace
VOO Vs. VTI: Here Are The Key Differences Between Vanguard US Stock Market ETFs Investors Should Know
Via Benzinga
Topics ETFs
This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock
Via The Motley Fool
Why Eli Lilly Stock's Big Jump Last Week Could Be Just the Beginning of Another Huge Run
Via The Motley Fool
Weight Loss Drugs Like Ozempic, Zepbound May Reduce Cancer Risks, Studies Suggest
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Eli Lilly To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
Via The Motley Fool
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Eli Lilly: A Pharmaceutical Juggernaut That Just Crushed Earnings Estimates
Via Talk Markets
A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.
Via The Motley Fool
MarketBeat Week in Review – 8/5 - 8/9
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
3 Stocks to Load-Up On Before Autumn Arrives
Via InvestorPlace
Lilly Stock Surging On Healthy Profits: Check Out Who's On The IBD 50, Other Premium Lists
Via Investor's Business Daily
S&P 500 Erases Weekly Losses, Nasdaq 100 Ends 4-Week Slide As Bulls Regain Momentum: Friday's Stock Movers At The Close
Via Benzinga
Topics Stocks
Exposures US Equities
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
Via Benzinga
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.